Neogenomics (NEO) is an operator of a network of cancer-focused genetic testing laboratories. The Company operates in Laboratory Testing Segment. This segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers.
The medical research stocks have been doing very well.
I’ve been watching the stock for about a year and it’s been moving up nicely since. With the end of the year coming I decided to look into some low risk trades. NEO does not have weekly options but I like the Call that expire on Dec 18th. I bought 1000 shares at $44.95 and sold 10 contracts of the 12/18/20 $45 Calls. Clearly I’m in this trade for the premium. I received a premium $2.05 for $2050. If I get assigned this will be a real nice trade to end the year.
11/20/20 – Buy 1000 Shares NEO @ $44.95
11/20/20 – Sell to Open 10 NEO 12/18/20 $45.00 C @ $ 2.05 (+$2050)
Neo just received an upgrade with a price target of $50. This trade gets a Risk Factor 1.
Successful trading,
Steve
The Options Coach